HUL
HUL
FMCG F&OKey Fundamentals
LargecapDiversified FMCGFMCGTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 92.4%
Weaknesses
3- Stock is trading at 9.29 times its book value
- The company has delivered a poor sales growth of 6.51% over past five years.
- Earnings include an other income of Rs.4,933 Cr.
Growth Rate
AI Analysis — Bull vs Bear
Hindustan Unilever Ltd, with a market cap of ₹4,53,401 Cr, is India's largest FMCG company trading at a PE of 30.4x and a price-to-book of 9.34x. The company is virtually debt-free with a robust ROE of 31% (last year) and maintains a 92.4% dividend payout, though topline growth has been muted at a 2% CAGR over three years and the stock has declined 23% over the past one year.
- Near debt-free balance sheet provides significant financial flexibility and resilience through economic cycles
- Last-year ROE of 31% and 5-year average ROE of 22% indicate consistently high capital efficiency and strong competitive moats
- Dividend payout ratio of 92.4% with a current yield of 2.11% offers steady income in a sector where peers typically yield below 1.5%
- Compounded profit growth of 14% over 10 years demonstrates long-term earnings compounding ability despite revenue headwinds
- TTM profit growth of 4% is recovering alongside TTM sales growth of 6%, suggesting improving operating leverage after a period of volume softness
- 10-year compounded sales CAGR of 7% reflects durable demand for its portfolio of essential consumer staples across urban and rural India
- 10-year stock CAGR of 8% has been delivered with low financial risk given the debt-free status, offering a lower-volatility exposure to India's consumption story
- Stock has declined 23% over the past 1 year and delivered a negative 7% CAGR over 3 years, significantly underperforming broader market indices
- 3-year compounded sales growth of just 2% points to persistent volume and pricing challenges in the core FMCG portfolio
- Trading at 9.34x book value is a steep premium, leaving limited margin of safety if earnings growth does not accelerate
- Earnings quality is diluted by other income of ₹4,933 Cr, which flatters reported profits and may not be sustainable or recurring
- PE of 30.4x prices in meaningful future growth, yet 5-year sales CAGR is only 6.51%, creating a valuation-growth mismatch
- 5-year stock CAGR of -6% suggests the market has been de-rating the stock as growth expectations have moderated
- TTM revenue growth of 6% barely keeps pace with nominal GDP growth, indicating the company may be losing wallet share to emerging D2C and regional FMCG brands
- A 92.4% dividend payout, while shareholder-friendly, leaves very little retained earnings for organic reinvestment or inorganic growth opportunities
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- Regional player resurgence threat Sep 6
Management acknowledges resurgence of small and regional players in tea and detergent bars, growing significantly ahead of large players after vacating during peak inflation.
- Aggressive competitive spending required Sep 6
Aggregate media deployment in HUL's categories has increased over 20% YoY. Company commits to keeping share of voice ahead of share of market, pressuring near-term profitability.
- Material cost inflation persists Sep 6
HUL faces 8-10% material cost inflation, managing with calibrated price increases of 2-5%. Balancing premiumisation with mass market affordability remains a challenge.
- New India growth strategy unveiled Sep 9
HUL outlined volume-led growth strategy targeting 22-24% EBITDA margins, expanding into new categories like protein and skincare through premiumisation and market making.
- Strong margin and capital efficiency Sep 6
EBITDA margin hit 23.7% in Q4 FY26, at the higher end of guidance. ROE improved to 30.69% in FY26 with free cash flow margins consistently at 18-21%.
- Premiumisation delivering 2.5x growth Sep 6
Premium products growing at over 2.5x mass portfolio. Bodywash turnover tripled in three years, gaining ~400bps market share. Premium now targets 40% of incremental turnover.
- ₹2,000Cr capex for premium expansion Sep 6
Signed off ₹2,000 crore capex for capacity in premium liquid formats across Home Care, Personal Care and Beauty. Q1 FY27 delivered 10% underlying sales growth with 5% volume growth.
- Digital-first media transformation Sep 6
Digital media spending now exceeds 60% of total media spend, up from 32% two years ago. Influencer network of 30,000 creators has nearly doubled YoY.
- Boost crosses ₹1,000Cr milestone Sep 6
Boost became HUL's 21st brand in the ₹1,000 crore-plus club. Lifestyle Nutrition posted its fifth consecutive quarter of positive underlying volume growth with double-digit growth in Horlicks and Boost.
- Delhi HC bars Beco disparaging ads Sep 10
Delhi High Court granted interim injunction stopping Beco from airing comparative ads disparaging Surf Excel and Vim. HUL had moved court on Aug 20 over claims linking its products to skin irritation.
- Investor meets and Capital Markets Day Sep 4
HUL participated in three physical investor meetings in early September with Barclays and UBS, and released its Capital Markets Day 2026 'Winning in New India' presentation on Sep 4.
TL;DR: HUL is executing a well-articulated premiumisation and efficiency playbook, with Q4 FY26 EBITDA margins at 23.7%, strong volume-led growth of 5%, and aggressive ₹2,000Cr capex directed at premium categories. Key risks include regional player resurgence in mass segments and rising competitive ad spending that could pressure near-term margins. The strategic direction is clearly improving, but sustained execution through FY27 will determine whether the premium valuation is justified.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15,496 | 15,623 | 15,567 | 15,210 | 15,707 | 15,926 | 15,556 | 15,190 | 15,757 | 15,919 | 16,441 | 16,351 | 17,341 |
| Expenses | 11,832 | 11,828 | 11,902 | 11,675 | 11,965 | 12,139 | 11,867 | 11,572 | 12,118 | 12,137 | 12,660 | 12,514 | 13,394 |
| Operating Profit | 3,664 | 3,795 | 3,665 | 3,535 | 3,742 | 3,787 | 3,689 | 3,618 | 3,639 | 3,782 | 3,781 | 3,837 | 3,947 |
| OPM % | 24% | 24% | 24% | 23% | 24% | 24% | 24% | 24% | 23% | 24% | 23% | 23% | 23% |
| Other Income | 146 | 178 | 184 | 309 | 209 | 203 | 733 | 149 | 103 | 269 | 4,048 | 503 | 113 |
| Interest | 50 | 88 | 91 | 105 | 93 | 110 | 109 | 77 | 122 | 124 | 88 | 76 | 75 |
| Depreciation | 286 | 297 | 313 | 320 | 329 | 338 | 318 | 318 | 326 | 322 | 337 | 348 | 353 |
| PBT | 3,474 | 3,588 | 3,445 | 3,419 | 3,529 | 3,542 | 3,995 | 3,372 | 3,294 | 3,605 | 7,404 | 3,916 | 3,632 |
| Tax % | 26% | 26% | 27% | 25% | 26% | 27% | 25% | 27% | 16% | 25% | 11% | 24% | 26% |
| Net Profit | 2,556 | 2,657 | 2,508 | 2,561 | 2,612 | 2,595 | 2,989 | 2,475 | 2,768 | 2,694 | 6,603 | 2,994 | 2,680 |
| EPS in Rs | 10.87 | 11.3 | 10.68 | 10.89 | 11.11 | 11.03 | 12.7 | 10.49 | 11.73 | 11.43 | 28.12 | 12.73 | 11.38 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 31,972 | 32,186 | 33,162 | 35,545 | 39,310 | 39,783 | 47,028 | 52,446 | 60,580 | 61,896 | 61,328 | 64,468 | 66,052 |
| Expenses | 26,560 | 26,276 | 26,834 | 28,046 | 30,430 | 29,922 | 35,402 | 39,589 | 46,433 | 47,237 | 46,630 | 49,429 | 50,705 |
| Operating Profit | 5,412 | 5,910 | 6,328 | 7,499 | 8,880 | 9,861 | 11,626 | 12,857 | 14,147 | 14,659 | 14,698 | 15,039 | 15,347 |
| OPM % | 17% | 18% | 19% | 21% | 23% | 25% | 25% | 25% | 23% | 24% | 24% | 23% | 23% |
| Other Income | 1,247 | 486 | 606 | 353 | 322 | 424 | 170 | 219 | 448 | 817 | 1,355 | 4,923 | 4,933 |
| Interest | 18 | 17 | 35 | 26 | 33 | 118 | 117 | 106 | 114 | 334 | 381 | 410 | 363 |
| Depreciation | 322 | 353 | 432 | 520 | 565 | 1,002 | 1,074 | 1,091 | 1,137 | 1,216 | 1,253 | 1,333 | 1,360 |
| PBT | 6,320 | 6,026 | 6,467 | 7,306 | 8,604 | 9,165 | 10,605 | 11,879 | 13,344 | 13,926 | 14,419 | 18,219 | 18,557 |
| Tax % | 31% | 31% | 31% | 28% | 30% | 26% | 25% | 25% | 24% | 26% | 26% | 17% | — |
| Net Profit | 4,376 | 4,151 | 4,490 | 5,227 | 6,060 | 6,756 | 7,999 | 8,892 | 10,143 | 10,282 | 10,671 | 15,059 | 14,971 |
| EPS in Rs | 20.17 | 19.18 | 20.68 | 24.09 | 27.97 | 31.17 | 34.03 | 37.79 | 43.07 | 43.74 | 45.32 | 64.01 | 63.66 |
| Div. Payout % | 74% | 83% | 82% | 83% | 78% | 80% | 119% | 90% | 91% | 96% | 117% | 64% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 216 | 216 | 216 | 216 | 216 | 216 | 235 | 235 | 235 | 235 | 235 | 235 |
| Reserves | 3,811 | 6,357 | 6,528 | 7,065 | 7,651 | 8,013 | 47,439 | 48,826 | 50,069 | 50,983 | 49,167 | 48,504 |
| Borrowings | 43 | 177 | 277 | 0 | 99 | 0 | 0 | 1,043 | 1,219 | 1,484 | 1,648 | 1,478 |
| Other Liabilities | 10,359 | 8,043 | 8,685 | 10,581 | 10,663 | 11,924 | 21,066 | 20,402 | 21,554 | 25,787 | 28,813 | 29,521 |
| Total Liabilities | 14,430 | 14,793 | 15,706 | 17,862 | 18,629 | 20,153 | 68,740 | 70,506 | 73,077 | 78,489 | 79,863 | 79,738 |
| Fixed Assets | 2,821 | 3,258 | 4,419 | 4,528 | 4,715 | 5,479 | 51,443 | 51,473 | 52,678 | 53,744 | 54,335 | 57,428 |
| CWIP | 516 | 408 | 229 | 461 | 406 | 597 | 745 | 1,313 | 1,132 | 1,025 | 1,009 | 880 |
| Investments | 3,025 | 2,592 | 3,794 | 2,873 | 2,716 | 1,255 | 2,709 | 3,521 | 2,882 | 4,625 | 3,810 | 4,359 |
| Other Assets | 8,067 | 8,535 | 7,264 | 10,000 | 10,792 | 12,822 | 13,843 | 14,199 | 16,385 | 19,095 | 20,709 | 17,071 |
| Total Assets | 14,430 | 14,793 | 15,706 | 17,862 | 18,629 | 20,153 | 68,740 | 70,506 | 73,077 | 78,489 | 79,863 | 79,738 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 3,292 | 4,171 | 5,185 | 6,059 | 5,800 | 7,623 | 9,163 | 9,048 | 9,991 | 15,469 | 11,886 | 10,999 |
| Investing | 138 | -282 | -1,173 | -1,063 | -438 | 1,791 | -1,228 | -1,728 | -1,484 | -5,324 | 6,473 | -3,676 |
| Financing | -3,462 | -3,864 | -4,214 | -4,975 | -5,390 | -6,819 | -9,309 | -8,015 | -8,953 | -10,034 | -13,101 | -10,810 |
| Net Cash Flow | -33 | 25 | -202 | 21 | -28 | 2,595 | -1,374 | -695 | -446 | 111 | 5,258 | -3,487 |
| Free Cash Flow | 3,246 | 3,460 | 4,248 | 5,196 | 5,046 | 6,813 | 5,097 | 7,995 | 8,980 | 14,012 | 10,624 | 9,667 |
| CFO/OP | 95 | 100 | 111 | 111 | 96 | 103 | 100 | 92 | 93 | 108 | 96 | 105 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 12 | 14 | 12 | 13 | 17 | 11 | 14 | 16 | 19 | 18 | 23 | 19 |
| Inventory Days | 77 | 75 | 67 | 65 | 59 | 65 | 66 | 65 | 55 | 55 | 61 | 61 |
| Days Payable | 148 | 156 | 164 | 185 | 166 | 176 | 163 | 145 | 123 | 143 | 156 | 169 |
| Cash Conversion Cycle | -60 | -67 | -85 | -107 | -90 | -101 | -83 | -64 | -50 | -70 | -72 | -89 |
| Working Capital Days | -53 | -26 | -35 | -37 | -30 | -31 | -32 | -22 | -15 | -22 | -34 | -23 |
| ROCE % | 139% | 112% | 91% | 103% | 116% | 117% | 39% | 25% | 27% | 27% | 28% | 28% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view HUL insights
73 extracted metrics + investor summaries across FY09–FY27.
Documents
Frequently Asked Questions about HUL
What does Hindustan Unilever Ltd do?
Where is Hindustan Unilever Ltd (HINDUNILVR) listed?
Which sector does Hindustan Unilever Ltd belong to?
What is the market capitalisation of Hindustan Unilever Ltd?
What is the PE ratio of Hindustan Unilever Ltd?
What is the 52-week high and low of Hindustan Unilever Ltd?
Does Hindustan Unilever Ltd pay dividends?
What is the Return on Equity (ROE) of Hindustan Unilever Ltd?
Company Information
Hindustan Unilever is in the FMCG business comprising primarily of Home Care, Beauty & Personal Care and Foods & Refreshment segments. The Company has manufacturing facilities across the country and sells primarily in India.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/HINDUNILVR.md for Hindustan Unilever Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.